NURIX Trademark

Trademark Overview

On Tuesday, October 1, 2019, a trademark application was filed for NURIX with the United States Patent and Trademark Office. The USPTO has given the NURIX trademark a serial number of 88637426. The federal status of this trademark filing is REGISTERED as of Tuesday, September 14, 2021. This trademark is owned by Nurix Therapeutics, Inc.. The NURIX trademark is filed in the Pharmaceutical Products category with the following description:

Biological and pharmaceutical preparations for the treatment of cancer and immune-related disorders
nurix

General Information

Serial Number88637426
Word MarkNURIX
Filing DateTuesday, October 1, 2019
Status700 - REGISTERED
Status DateTuesday, September 14, 2021
Registration Number6486938
Registration DateTuesday, September 14, 2021
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 28, 2020

Trademark Statements

Goods and ServicesBiological and pharmaceutical preparations for the treatment of cancer and immune-related disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, October 4, 2019
Primary Code005
First Use Anywhere DateMonday, June 21, 2021
First Use In Commerce DateMonday, June 21, 2021

Trademark Owner History

Party NameNurix Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBrisbane, CA 94005
Party NameNurix Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94158
Party NameNurix Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94158

Trademark Events

Event DateEvent Description
Friday, October 4, 2019NEW APPLICATION ENTERED
Friday, October 4, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 19, 2019ASSIGNED TO EXAMINER
Friday, December 20, 2019EXAMINERS AMENDMENT -WRITTEN
Friday, December 20, 2019EXAMINERS AMENDMENT E-MAILED
Friday, December 20, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, December 20, 2019EXAMINER'S AMENDMENT ENTERED
Saturday, December 21, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, December 26, 2019ASSIGNED TO LIE
Wednesday, January 8, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 28, 2020PUBLISHED FOR OPPOSITION
Tuesday, January 28, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 24, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, September 18, 2020SOU TEAS EXTENSION RECEIVED
Friday, September 18, 2020SOU EXTENSION 1 FILED
Friday, September 18, 2020SOU EXTENSION 1 GRANTED
Tuesday, September 22, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 5, 2021SOU TEAS EXTENSION RECEIVED
Friday, March 5, 2021SOU EXTENSION 2 FILED
Friday, March 5, 2021SOU EXTENSION 2 GRANTED
Tuesday, March 9, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 25, 2021TEAS STATEMENT OF USE RECEIVED
Wednesday, July 7, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, June 25, 2021USE AMENDMENT FILED
Thursday, July 8, 2021STATEMENT OF USE PROCESSING COMPLETE
Tuesday, August 10, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, August 11, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, September 14, 2021REGISTERED-PRINCIPAL REGISTER
Monday, November 24, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, November 24, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, November 24, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, November 24, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, November 24, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED

Related Keywords

nurix immune related disorders cancer treatment pharmaceutical preparations biological